The University of Texas MD Anderson Cancer Center is a comprehensive cancer center in Houston, Texas. It is the largest cancer center in the U.S. and one of the original three comprehensive cancer centers in the country.

During the past decade, M D Anderson Cancer Center conducted 2943 clinical trials. In the 10-year time frame, 2943 clinical trials started and 1217 clinical trials were completed, i.e. on average, 41.4% percent of trials that started reached the finish line to date. In the past 5 years, 1481 clinical trials started and 742 clinical trials were completed. i.e. 50.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "M D Anderson Cancer Center" #1 sponsor was "M.D. Anderson Cancer Center" with 2407 trials, followed by "National Cancer Institute (NCI)" with 340 trials sponsored, "Novartis Pharmaceuticals" with 105 trials sponsored, "Children's Oncology Group" with 101 trials sponsored and "Pfizer" with 101 trials sponsored. Other sponsors include 2658 different institutions and companies that sponsored additional 862 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "M D Anderson Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 1486 trials as a collaborator, "M.D. Anderson Cancer Center" with 124 trials as a collaborator, "Bristol-Myers Squibb" with 84 trials as a collaborator, "Merck Sharp & Dohme LLC" with 76 trials as a collaborator and "NRG Oncology" with 70 trials as a collaborator. Other collaborators include 2126 different institutions and companies that were collaborators in the rest 779 trials.

According to Clinical.Site data, the most researched conditions in "M D Anderson Cancer Center" are "Breast Cancer" (265 trials), "Leukemia" (265 trials), "Lymphoma" (204 trials), "Acute Myeloid Leukemia" (170 trials) and "Lung Cancer" (140 trials). Many other conditions were trialed in "M D Anderson Cancer Center" in a lesser frequency.

Most popular intervention types in "M D Anderson Cancer Center" are "Drug" (4147 trials), "Other" (1159 trials), "Biological" (870 trials), "Procedure" (851 trials) and "Radiation" (475 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (345 trials), "Questionnaire Administration" (300 trials), "Cyclophosphamide" (231 trials), "Quality-of-Life Assessment" (216 trials) and "Placebo" (190 trials). Other intervention names were less common.

The vast majority of trials in "M D Anderson Cancer Center" are 4994 trials for "All" genders, 525 trials for "Female" genders and 174 trials for "Male" genders.

Currently, there are 2261 active trials in "M D Anderson Cancer Center". 44 are not yet recruiting, 1313 are recruiting, 892 are Active, not recruiting, and 12 are Enrolling by invitation. In total, there were 2495 completed trials in M D Anderson Cancer Center, 23 suspended trials, and 674 terminated clinical trials to date.

Out of the total trials that were conducted in M D Anderson Cancer Center, 1943 "Phase 1" clinical trials were conducted, 2659 "Phase 2" clinical trials and 704 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 47 trials, and there were also 474 trials that are defined as “Not Applicable".

M D Anderson Cancer Center has several departments that took part in Clinical trials: "University of Texas/MD Anderson Cancer Center Dept of Onc." - 12 trials, "University of Texas/MD Anderson Cancer Center Gastrointestinal Med. Oncology" - 5 trials, "University of Texas M. D. Anderson Cancer Center - Investigational Cancer Therapeutics - Partner" - 4 trials, "University of Texas MD Anderson Cancer Center - Unit 432 Thoracic Head and Neck Medical Oncology" - 4 trials, "The University of Texas - MD Anderson Cancer Center - Infectious Diseases" - 3 trials, "MD ANDERSON CANCER CENTER (Data Collection Only)" - 3 trials, "Uni of Texas - Md Anderson Cancer Center; Dept of Breast Medical Oncology" - 2 trials, "MD Anderson Cancer Center Department of Lymphoma & Myeloma" - 2 trials, "MD Anderson Cancer Center, Department of Leukemia" - 2 trials